Clough Capital Partners’s DexCom DXCM Stock Holding History

Clough Capital Partners’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,670	Closed	-$495K	–	122
2025 Q2	$495K	Hold	5,670	–	–	0.05%	110
2025 Q1	$387K	Sell	5,670 -160,180	-97%	-$13.1M	0.05%	102
2024 Q4	$12.9M	Buy	+165,850	New	+$12.3M	1.46%	23
2024 Q2	–	Sell	-102,357	Closed	-$14.2M	–	124
2024 Q1	$14.2M	Sell	102,357 -25,014	-20%	-$3.14M	1.56%	21
2023 Q4	$15.8M	Buy	127,371 +19,791	+18%	+$2.02M	1.75%	16
2023 Q3	$10M	Buy	+107,580	New	+$12.1M	1.08%	28
2022 Q2	–	Sell	-16,400	Closed	-$2.1M	–	94
2022 Q1	$2.1M	Buy	+16,400	New	+$1.79M	0.16%	85

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Clough Capital Partners's DXCM Position: Q3 2025 in Review

Clough Capital Partners sold out of DexCom (DXCM) in Q3 2025, closing a stake of 5,670 shares — an estimated $495K sold.

Clough Capital Partners first reported a position in DXCM in Q1 2022 and held it in 7 quarters. The position peaked at $15.8M in Q4 2023. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

Clough Capital Partners reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
Clough Capital Partners sold 5,670 DexCom shares in Q3 2025, an estimated $495K.
Clough Capital Partners first reported a position in DexCom in Q1 2022 and held it in 7 quarters.
Clough Capital Partners's DexCom position peaked at $15.8M in Q4 2023.
911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Clough Capital Partners's 13F filing for Q3 2025, filed 14 Nov 2025.